To investigate the factors associated with compliance with recommendations regarding liver cancer screening intervals and methods among individuals at high-risk for liver cancer in the Republic of Korea. We used data from the fourth Korean National Health and Nutrition Examination Survey (KNHANES IV), a representative cross-sectional nationwide survey conducted between 2007 and 2009. The liver cancer screening rate and factors associated with compliance with recommended screening intervals (6 months) and methods (both abdominal ultrasonography and serum alpha-fetoprotein testing) among individuals at high risk for liver cancer such as hepatitis B virus (HBV) carriers were investigated. Out of 24,871 KNHANES IV participants, 604 HBV carriers...
Background: Liver cancer is the second most-frequent cause of cancer death in Korea. Hepatitis B vir...
BackgroundHepatitis B virus (HBV) infection disproportionately affects Asian Americans but HBV scree...
surpass all other groups with respect to liver cancer incidence and mortality. An estimated 80%–85 %...
To investigate the factors associated with compliance with recommendations regarding liver cancer sc...
BACKGROUND : The Korean National Cancer Screening Programme (NCSP) for liver cancer was initiated in...
BACKGROUND AND AIMS: The National Cancer Screening Program (NCSP) for liver cancer was initiated in ...
The Republic of Korea (hereafter Korea) is one of the countries with high incidence of liver cancer ...
We investigated the cancer screening rates for five types of cancer (stomach, liver, colorectal, bre...
BACKGROUND:The National Liver Cancer Surveillance Program (NLCSP) targets patients with liver diseas...
This study was conducted to determine the use of screening for stomach, liver, colorectal, breast, a...
Hepatocellular carcinoma (HCC) is one of the major cancers with a high incidence and mortality in Ko...
Hepatocellular carcinoma (HCC) is a highly malignant cancer and third major cause of death in Korean...
<p><sup>a</sup> High risk group of Liver cancer includes patients with cirrhosis, chronic liver dise...
BACKGROUND: Cancer is one of the leading causes of death in Korea. To reduce cancer incidence, the K...
Hepatocellular carcinoma (HCC) is a highly malignant cancer and the fifth common cancer in the World...
Background: Liver cancer is the second most-frequent cause of cancer death in Korea. Hepatitis B vir...
BackgroundHepatitis B virus (HBV) infection disproportionately affects Asian Americans but HBV scree...
surpass all other groups with respect to liver cancer incidence and mortality. An estimated 80%–85 %...
To investigate the factors associated with compliance with recommendations regarding liver cancer sc...
BACKGROUND : The Korean National Cancer Screening Programme (NCSP) for liver cancer was initiated in...
BACKGROUND AND AIMS: The National Cancer Screening Program (NCSP) for liver cancer was initiated in ...
The Republic of Korea (hereafter Korea) is one of the countries with high incidence of liver cancer ...
We investigated the cancer screening rates for five types of cancer (stomach, liver, colorectal, bre...
BACKGROUND:The National Liver Cancer Surveillance Program (NLCSP) targets patients with liver diseas...
This study was conducted to determine the use of screening for stomach, liver, colorectal, breast, a...
Hepatocellular carcinoma (HCC) is one of the major cancers with a high incidence and mortality in Ko...
Hepatocellular carcinoma (HCC) is a highly malignant cancer and third major cause of death in Korean...
<p><sup>a</sup> High risk group of Liver cancer includes patients with cirrhosis, chronic liver dise...
BACKGROUND: Cancer is one of the leading causes of death in Korea. To reduce cancer incidence, the K...
Hepatocellular carcinoma (HCC) is a highly malignant cancer and the fifth common cancer in the World...
Background: Liver cancer is the second most-frequent cause of cancer death in Korea. Hepatitis B vir...
BackgroundHepatitis B virus (HBV) infection disproportionately affects Asian Americans but HBV scree...
surpass all other groups with respect to liver cancer incidence and mortality. An estimated 80%–85 %...